Worrying News for Abiomed Shareholders?
Medical device maker Abiomed (NAS: ABMD) reported great results for the second quarter of fiscal 2013 today, but despite strong revenue growth, the stock took a massive 30% plunge.
In the following video, health care analysts Max Macaluso and David Williamson discuss Abiomed's earnings report and the reasons behind today's dramatic decline.
While you can certainly make huge gains -- and sometimes losses -- in the health care space, the best investing approach is to choose great companies and stick with them for the long term. In our free report "3 Stocks That Will Help You Retire Rich," we name stocks that could help you build long-term wealth and retire well, along with some winning strategies that every investor should be aware of. Click here now to keep reading.
The article Worrying News for Abiomed Shareholders? originally appeared on Fool.com.Max Macaluso, Ph.D. and David Williamson have no positions in the stocks mentioned above. The Motley Fool has no positions in the stocks mentioned above. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.